HOME >> BIOLOGY >> NEWS
Enzyme once thought harmful to Alzheimers patients now appears key to future treatment

March 12, 2002 -- Bethesda, MD -- The four million Americans who have been diagnosed with Alzheimers disease (AD) experience symptoms which include progressive mental deterioration, confusion, a loss of memory and an inability to calculate the simplest of numbers. This may be due to the fact that people with Alzheimer's have fewer brain cells and less of some important neurotransmitters than people without the disease.

The Importance of Galanin
Previous research has established that a substance called galanin is associated with learning and memory and is involved in brain function, and disorders such as epilepsy. When a nerve is cut or injured, the neuron produces extra galanin, possibly to repair or modulate the damage. The production of galanin may be one way that the body tries to repair nerve damage. Unfortunately, accepted literature states when the onset of AD occurs, galanin hyperinnervation (excessive supply) of nerve cells that employ acetylcholine as their neurotransmitter in the basal forebrain of AD patients occurs and depresses acetylcholine release and its inhibitory actions at other central nervous system sites.

Background
The majority of the scientific community believes this action is detrimental. This is due to a finding that AD wipes out many of the cholinergic neurons of the hippocampus; those that survive in the nucleus show elevated expression of galanin. However, a new study suggests that by virtue of its excitatory actions on cholinergic neurons, galanin may in fact play a compensatory role by enhancing the release of acetylcholine from remaining cholinergic basal forebrain neurons. This action might serve to delay the progression of Alzheimer's disease linked to a reduction in central cholinergic tone. This raises the possibility that induction of galanin by nerve growth factor may have a neuroprotective role.

The Study
To examine this theory, an investigation of the mechanism of action of this
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
14-Mar-2002


Page: 1 2 3

Related biology news :

1. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
2. Enzyme activation appears key in helping internal clock tell night from day
3. Enzyme fully degrades mad cow disease prion
4. Enzyme revealed that is key to funguss ability to breach immune system
5. Enzyme discovery sheds light on causes of rare disease, cancer
6. Enzyme could overcome industrial bleaching waste problems
7. Enzyme controls good cholesterol
8. Enzyme discovery to benefit homeland security, industry
9. Enzyme could aid cancer fight
10. Enzyme mimetic reduces tissue damage in colitis animal study
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
Cached News: